GU CONNECT expert, Assoc. Prof. Shilpa Gupta provides a urothelial cancer update from ASCO GU 2020 for you.
Urothelial cancer update by Assoc. Prof. Shilpa Gupta, University of Minnesota, Minneapolis, USA
GU CONNECT expert, Assoc. Prof. Shilpa Gupta provides a urothelial cancer update from ASCO GU 2020 for you.
Urothelial cancer update by Assoc. Prof. Shilpa Gupta, University of Minnesota, Minneapolis, USA
Shilpa Gupta, MD is an Associate Professor in the Division of Hematology, Oncology and Transplantation and the lead for the Phase 1 Interdisciplinary Solid Tumor Program at the Masonic Cancer Center, University of Minnesota, Minneapolis, USA. Prior to joining the University of Minnesota in July 2015, Dr Gupta was faculty in Genitourinary Oncology and Experimental Therapeutics at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida for 4 years. Dr Gupta’s clinical and research interests are to treat patients with genitourinary malignancies and develop novel trials using targeted therapies and immunotherapies. She is currently the Principal investigator of several early and late phase trials in genitourinary oncology. Dr Gupta is passionate about her research and has published her research across a variety of peer-reviewed journals and book chapters. Twitter: @shilpaonc Email:guptash@umn.edu
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Make decisions for your patient at two key stages in their journey
Experts discuss new lung cancer data at a meeting hosted by eChinaHealth and COR2ED
Share the survey with patients with lung cancer and their caregivers
Explore pre-analytical phase challenges and biomarker testing in lung cancer. Moderated by the Oncology Brothers.
Follow a patient's journey during and post-elacestrant treatment for ER+/HER2- metastatic breast cancer